We measured CFB expression in both stroma and cytoplasm of tumor cells and found that among the 113 cases, 77 cases (68 %) were classified as high stromal CFB and 36 cases (32 %) as low stromal CFB, while 60 cases (53 %) were classified as high cytoplasmic CFB and 53 cases (47 %) as low cytoplasmic CFB. This evidence concerns the gene CFB and neoplasm.